Susceptibility gene for myocardial infarction

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) C07H 21/04 (2006.01) C07K 14/47 (2006.01) C12N 15/11 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) C12N 9/02 (2006.01)

Patent

CA 2502359

Linkage of Myocardial Infarction (MI) and a locus on chromosome 13q12 is disclosed. In particular, the FLAP gene within this locus is shown by association analysis to be a susceptibility gene for MI. Pathway targeting for drug delivery and diagnosis applications in identifying those have MI or at risk of developing MI, in particular are described.

L'invention concerne la liaison entre un infarctus du myocarde (IM) et un site du chromosome 13q12. L'invention concerne en particulier le gène FLAP de ce site qui, par analyse d'association, s'est révélé être un gène de susceptibilité d'un infarctus du myocarde (IM). L'invention concerne tout particulièrement le ciblage d'une voie d'administration de médicaments, ainsi que des applications de diagnostic permettant d'identifier les personnes atteintes d'un infarctus du myocarde ou susceptibles de développer un infarctus du myocarde (IM).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Susceptibility gene for myocardial infarction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Susceptibility gene for myocardial infarction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Susceptibility gene for myocardial infarction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2023606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.